Cataract Clinical Trial
— FLIRTOfficial title:
The Femtosecond Laser in Residency Training (FLIRT) Pilot Study: Femtosecond Laser-Assisted Versus Manual Cataract Extraction and Intraocular Lens Implantation
NCT number | NCT03115216 |
Other study ID # | FLIRT |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2017 |
Est. completion date | July 2018 |
Verified date | April 2017 |
Source | University of Southern California |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot study aims to primarily assess the rate of complication of anterior vitrectomy for patients undergoing femtosecond laser-assisted (FLA) cataract extraction and intraocular lens placement (CEIOL) compared to manual CEIOL, when performed by resident physicians under direct attending supervision. In this pilot study, the investigators aim to assess what the incidence of anterior vitrectomy is for each group, in order to better understand the sample size needed to assess whether there is a difference between these two groups. Secondarily, it will gather preliminary data on safety and refractive outcomes for patients undergoing these interventions.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 2018 |
Est. primary completion date | July 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years and older |
Eligibility |
Inclusion Criteria: - Patients of the Los Angeles County + University of Southern California Medical Center (LAC+USC) who are 40 years or older with visually significant cataracts asking for surgical intervention. - Cataract must be visually and clinically significant on examination as determined by the resident surgeon and the attending physician. Exclusion Criteria: - Age less than 40 - Visual acuity 20/30 or better with refraction in the study eye - Any previous ocular surgery - Patient request for monovision or for correction at near at the expense of distance - Patient and physician decision to use an IOL implant other than monofocal IOL - Corneal pathology (e.g. Fuch's dystrophy, corneal opacity or scar, corneal ectasia) - Posterior or anterior capsular plaque - Posterior polar cataract - White cataract - Subluxated lens, weak zonules, or phacodonesis - Pseudoexfoliation syndrome - Failure of preoperative pupillary dilatation (< 6 mm dilation) - History of uveitis - History of retinal detachment - Untreated or active proliferative diabetic retinopathy - Untreated or active diabetic macular edema - Ocular diseases that may affect visual acuity or the operation (including and not limited to macular degeneration, retinitis pigmentosa, macular hole, advanced or end-stage glaucoma) - Neurological or systemic diseases that may affect visual acuity or the safety of the operation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Southern California | Alcon Research |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of anterior vitrectomy | Of all cases in each group, what percent results in any complication that needed conversion to anterior vitrectomy | 6 months | |
Secondary | Incidence of dropped nucleus or intraocular lens (IOL) | Complication when the nucleus or implanted intraocular lens falls posteriorly | 6 months | |
Secondary | Incidence of posterior capsular tear | Complication where the posterior capsule is torn or ruptured | 6 months | |
Secondary | Incidence of anterior capsular tears or tags | Complication where the anterior capsule is torn or ruptured | 6 months | |
Secondary | Incidence of zonal injury | Complication where the cataractous nucleus or implanted IOL falls posteriorly. | 6 months | |
Secondary | Incidence of corneal injury | Complication when the cornea is injured during surgery | 6 months | |
Secondary | New onset macular edema | Presence of macular edema, by clinical evaluation or optical coherence tomography (OCT), which was not present before surgery | 6 months | |
Secondary | New onset ocular hypertension or glaucoma | Ocular hypertension or glaucoma, which was not present before surgery | 6 months | |
Secondary | Postoperative outcomes such as uncorrected and best corrected distance visual acuity | Measured by manifest refraction | 6 months | |
Secondary | Contrast sensitivity | Measured by Pelli-Robson Contrast Sensitivity Chart and the Contrast Sensitivity Testing (CSV-1000E) | 6 months | |
Secondary | Spherical equivalent | Calculated from the best corrected visual acuity | 6 months | |
Secondary | Corneal edema | Graded by the surgeon on a scale of 0 to 3 (none, mild, moderate, severe) | 6 months | |
Secondary | Central corneal thickness | Measured by pachymetry | 6 months | |
Secondary | Intraocular lens centration | Subjectively graded by the surgeon on a scale of 0 to 4 (poor, average, fair, excellent centration). | 6 months | |
Secondary | Educational gains of the resident surgeon | Done through surveys distributed to resident physicians throughout the course of the study | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |